Patrizia Giannatempo

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

Andrea Necchi, Andrea Anichini, Daniele Raggi et al. · Journal of Clinical Oncology · 2018 · 734 citations

Medicine, Oncology, Urology +17

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Friedemann Honecker, Jorge Aparicio, Daniel M. Berney et al. · Annals of Oncology · 2018 · 328 citations · Full text

Medicine, Oncology, Surgery +16

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

Andrea Necchi, Daniele Raggi, Andrea Gallina et al. · European Urology · 2019 · 320 citations

Medicine, Oncology, Urology +12

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

Andrea Necchi, Daniele Raggi, Andrea Gallina et al. · European Urology · 2020 · 178 citations

Medicine, Immunology, Oncology +17

Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial

Andrea Necchi, Luigi Mariani, Nadia Zaffaroni et al. · The Lancet Oncology · 2012 · 145 citations

Medicine, Oncology, Pharmacology +7